Search This Blog

Friday, January 11, 2019

Morgan Stanley reports 5.3% passive stake in ImmunoGen


In a regulatory filing, Morgan Stanley disclosed a 5.3% stake in ImmunoGen, which represents about 8M shares. The filing does not allow for activism.
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)